Wood Ear Mushroom: Blood Flow, Blood Sugar, and Cardiovascular Health

Evidence Review

Blood Sugar: Animal Models

Yuan et al. (1998) conducted an eight-week intervention in KK-Ay mice, a strain with a genetic predisposition to type 2 diabetes. The water-soluble polysaccharide (FA fraction) from A. auricula-judae was fed at a level accounting for 5% of diet by weight [1]. Compared to controls:

• Plasma glucose was significantly reduced across the intervention period
• Serum insulin levels decreased, suggesting improved insulin sensitivity rather than just compensatory insulin increase
• Urinary glucose excretion fell substantially
• Hepatic glycogen content increased, indicating improved glucose storage
• Glucose tolerance tests showed a significantly blunted glucose peak

The polysaccharide also modestly reduced food intake, which the authors noted as a confounding factor, though they conducted pair-feeding experiments that attributed a significant portion of the glycemic effect to the polysaccharide itself rather than simply reduced caloric intake [1].

Later studies using metabolomics confirmed that Auricularia polysaccharides modulate glucokinase gene expression and alter the Firmicutes/Bacteroidetes ratio in gut microbiota toward a more metabolically favorable profile [5]. Human clinical trials specifically on wood ear mushroom and blood glucose remain limited.

Anticoagulant Activity

Yoon et al. (2004) purified an acidic polysaccharide from A. auricula using gel filtration chromatography and characterized its anticoagulant mechanism [2]. The isolated compound had an average molecular mass of approximately 160 kDa and was rich in glucuronic acid. Key findings:

• Anticoagulant activity of approximately 2 IU/mg using the activated partial thromboplastin time (APTT) assay
• Mechanism confirmed as antithrombin-mediated catalysis of thrombin inhibition — the same pathway exploited by pharmaceutical heparin, though by a structurally distinct polysaccharide
• The mushroom was confirmed non-toxic at relevant doses
• Heparin cofactor II (an alternative anticoagulant mechanism) was not involved

This is a well-characterized mechanistic study. The antithrombin pathway is physiologically important — antithrombin is the body's primary natural inhibitor of thrombin, the enzyme that converts fibrinogen to fibrin and is central to clot formation. A dietary compound that enhances antithrombin's activity represents a genuinely meaningful cardiovascular mechanism [2].

Antiplatelet Activity

Poniedziałek et al. (2019) screened eight common edible mushrooms (Agaricus bisporus, Auricularia auricularia-judae, Coprinus comatus, Ganoderma lucidum, Hericium erinaceus, Lentinula edodes, Pleurotus eryngii, and Pleurotus ostreatus) using hot water extracts tested against human platelets in vitro [4]. The study measured:

• Inhibition of ADP-induced platelet aggregation
• Inhibition of arachidonic acid (AA)-induced platelet aggregation
• Prothrombin time, prothrombin ratio, and INR (coagulation parameters)

Wood ear mushroom and Pleurotus eryngii produced the strongest antiplatelet effects among the eight species tested [4]. The inhibition of ADP-induced aggregation by wood ear extract exceeded 140 µmol/L aspirin. In the AA test, it was comparable to aspirin. No significant effect on formal coagulation parameters (PT, INR) was observed, suggesting the mechanism is primarily antiplatelet rather than affecting the coagulation cascade directly — complementary to the antithrombin-mediated anticoagulant findings of Yoon et al. [2][4].

Lipid Reduction and Liver Protection

Reza et al. (2015) administered a 70% ethanol extract of wood ear mushroom to mice at 200 and 400 mg/kg/day for four weeks while feeding a high-fat diet [3]. Results compared to high-fat diet controls showed:

• Significant reductions in serum total cholesterol, LDL cholesterol, and triglycerides
• Reduced hepatic triglyceride accumulation (fatty liver markers improved)
• Decreased expression of SREBP-1c and FAS, transcription factors and enzymes that drive fatty acid synthesis in the liver
• Increased CPT-1 activity, an enzyme responsible for transporting fatty acids into mitochondria for oxidation

The authors also confirmed these effects in isolated hepatocytes in vitro, supporting a direct hepatic mechanism rather than an indirect effect mediated by gut microbiota or systemic hormones [3].

Evidence Strength Summary

The blood sugar, anticoagulant, antiplatelet, and lipid research on wood ear mushroom is mechanistically robust and consistent across multiple independent research groups and animal models. The main limitation across all these studies is the near-total absence of randomized human clinical trials. The evidence supports including wood ear mushroom as a beneficial dietary food for cardiovascular and metabolic health, but the specific effect sizes in humans at culinary doses have not been formally established. It is particularly relevant for people focused on metabolic syndrome, blood sugar management, or reducing cardiovascular risk factors through diet.